Flash Freezing in Fluoropolymer Bottles
Technical notes | 2019 | SavillexInstrumentation
The rapid freezing of liquid formulations is critical to prevent the formation of large ice crystals that can compromise protein integrity and other sensitive biomolecules. Flash freezing down to liquid nitrogen temperatures (-196 °C) is widely employed in biopharmaceutical manufacturing but often leads to container failures that go undetected until thawing.
This study evaluated the structural integrity and seal performance of 1 L Purillex® PFA fluoropolymer bottles when subjected to extreme thermal conditions. The protocol, modeled after licensed biopharmaceutical flash‐freezing procedures, assessed bottle performance during dry heat sterilization, immersion in dry ice and liquid nitrogen, and repeated freeze cycles.
The experimental protocol included:
The materials and equipment employed included:
All test bottles, including controls, maintained integrity following the dry heat pretreatment. Bottles exposed to dry ice and liquid nitrogen showed no evidence of wall collapse and passed hydrostatic leak tests at both 2 psi and 15 psi. The subset of bottles subjected to a second liquid nitrogen cycle also retained full structural and seal integrity. These findings demonstrate the superior performance of fluoropolymer containers under rapid temperature transitions compared to traditional materials.
The robust performance of PFA fluoropolymer bottles offers several advantages:
Emerging developments may include:
This study confirms that Purillex® PFA fluoropolymer bottles can withstand dry heat sterilization at 250 °C and multiple flash‐freezing cycles to -196 °C without loss of structural integrity or seal performance. These results validate their suitability for critical biopharmaceutical processes where container reliability is paramount.
Consumables
IndustriesManufacturerSavillex
Summary
Importance of the Topic
The rapid freezing of liquid formulations is critical to prevent the formation of large ice crystals that can compromise protein integrity and other sensitive biomolecules. Flash freezing down to liquid nitrogen temperatures (-196 °C) is widely employed in biopharmaceutical manufacturing but often leads to container failures that go undetected until thawing.
Study Objectives and Overview
This study evaluated the structural integrity and seal performance of 1 L Purillex® PFA fluoropolymer bottles when subjected to extreme thermal conditions. The protocol, modeled after licensed biopharmaceutical flash‐freezing procedures, assessed bottle performance during dry heat sterilization, immersion in dry ice and liquid nitrogen, and repeated freeze cycles.
Methodology
The experimental protocol included:
- Thermal pretreatment at 250 °C for 120 minutes for all test and control bottles.
- Filling each bottle with 200 mL purified water and overnight conditioning at 21 °C.
- Application of closure torque using a calibrated dial torque wrench.
- Submersion of six bottles in dry ice for 24 hours and six bottles in liquid nitrogen for 30 minutes; four bottles underwent a second liquid nitrogen cycle.
- Visual inspection for wall collapse immediately post‐freeze.
- Hydrostatic leak testing at 2 psi and 15 psi with backlighting inspection for any leaks.
Used Instrumentation
The materials and equipment employed included:
- Purillex® PFA fluoropolymer bottles manufactured via injection molding and two‐step stretch blow molding to ensure precise neck and thread dimensions.
- Calibrated dial torque wrench for consistent closure torque application.
- Liquid nitrogen bath and dry ice setup for controlled freeze cycles.
- Hydrostatic leak test apparatus with pressure fittings and backlighting inspection system.
Key Results and Discussion
All test bottles, including controls, maintained integrity following the dry heat pretreatment. Bottles exposed to dry ice and liquid nitrogen showed no evidence of wall collapse and passed hydrostatic leak tests at both 2 psi and 15 psi. The subset of bottles subjected to a second liquid nitrogen cycle also retained full structural and seal integrity. These findings demonstrate the superior performance of fluoropolymer containers under rapid temperature transitions compared to traditional materials.
Benefits and Practical Applications
The robust performance of PFA fluoropolymer bottles offers several advantages:
- Secure containment of bulk drug substances during flash‐freezing operations.
- Compatibility with both high‐temperature sterilization and extreme cold, streamlining storage and handling workflows.
- Minimized risk of sample loss or contamination due to container failure.
Future Trends and Potential Applications
Emerging developments may include:
- Adaptation of fluoropolymer container technology to smaller volumes and vials for analytical and clinical applications.
- Integration into automated and high‐throughput freezing, storage, and transport systems.
- Advances in resin formulations to further enhance chemical resistance and mechanical strength.
Conclusion
This study confirms that Purillex® PFA fluoropolymer bottles can withstand dry heat sterilization at 250 °C and multiple flash‐freezing cycles to -196 °C without loss of structural integrity or seal performance. These results validate their suitability for critical biopharmaceutical processes where container reliability is paramount.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
Freeze Cycle Testing
2021|Savillex|Technical notes
Savillex Technical Note Freeze Cycle Testing Summary Storing frozen bulk drug substances (BDS) – including bioprocess solutions, vaccines, blood components, and other delicate process fluids – is common practice in the bioprocess industry. Vessels used to store these fluids must…
Key words
pass, passetfe, etfepfa, pfaclosure, closurefreeze, freezethaw, thawpiece, piecebottles, bottlesfluoropolymer, fluoropolymersavillex, savillexbottle, bottleintegrity, integrityethylenetetrafluoroethylene, ethylenetetrafluoroethylenepaneling, panelingprocedure
Freeze Drop Testing of Bulk Drug Substance Bottles
2020|Savillex|Technical notes
Savillex Technical Note Freeze Drop Testing of Bulk Drug Substance Bottles Summary Frozen storage of bulk drug substance (BDS) at temperatures at or below -70°C is common in the bioprocess industry. Storage at temperatures below -80°C can lead to spontaneous…
Key words
paneling, panelingthaw, thawleaking, leakingpetg, petgafter, afteretfe, etfepfa, pfabottles, bottlescracked, crackedbottom, bottomsavillex, savillexbottle, bottlecorner, cornerbds, bdsdrop
CO2 Transmission Into Bulk Drug Substance Containers
2021|Savillex|Technical notes
Savillex Technical Note CO2 Transmission Into Bulk Drug Substance Containers Summary Ingress of carbon dioxide into bulk drug substance (BDS) containers that are stored and shipped on dry ice is a serious and often understated problem. Although all bag systems…
Key words
closure, closurebottle, bottlepurillex, purillexingress, ingresstorque, torquebottles, bottlespounds, poundsdioxide, dioxidesavillex, savillexfloating, floatinginch, inchinsert, insertneck, neckdry, dryice
Freeze Mapping - Savillex Fluoropolymer Bottles
2021|Savillex|Technical notes
Savillex Technical Note Freeze Mapping - Savillex Fluoropolymer Bottles Summary The ability to freeze bulk drug substance (BDS) at temperatures at or below -80°C is critical to the bioprocess industry – as are rapid and efficient freezing and thawing processes.…
Key words
freezing, freezingfreeze, freezesavillex, savillexthaw, thawfluoropolymer, fluoropolymerbottles, bottlesbottle, bottleflash, flashbds, bdsdatalogger, dataloggerbath, baththermocouples, thermocoupleswater, waterpurillex, purillexsupportive